752 related articles for article (PubMed ID: 2459499)
1. Induction of oligodendrocyte proliferation and remyelination after chronic demyelination. Relevance to multiple sclerosis.
Raine CS; Moore GR; Hintzen R; Traugott U
Lab Invest; 1988 Oct; 59(4):467-76. PubMed ID: 2459499
[TBL] [Abstract][Full Text] [Related]
2. Chronic relapsing experimental autoimmune encephalomyelitis. Ultrastructure of the central nervous system of animals treated with combinations of myelin components.
Raine CS; Traugott U
Lab Invest; 1983 Mar; 48(3):275-84. PubMed ID: 6186840
[TBL] [Abstract][Full Text] [Related]
3. Inflammation stimulates remyelination in areas of chronic demyelination.
Foote AK; Blakemore WF
Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
[TBL] [Abstract][Full Text] [Related]
4. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
Meeson AP; Piddlesden S; Morgan BP; Reynolds R
Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
[TBL] [Abstract][Full Text] [Related]
5. Astrocytes express insulin-like growth factor-I (IGF-I) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune encephalomyelitis.
Liu X; Yao DL; Bondy CA; Brenner M; Hudson LD; Zhou J; Webster HD
Mol Cell Neurosci; 1994 Oct; 5(5):418-30. PubMed ID: 7529631
[TBL] [Abstract][Full Text] [Related]
6. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
Butzkueven H; Emery B; Cipriani T; Marriott MP; Kilpatrick TJ
Glia; 2006 May; 53(7):696-703. PubMed ID: 16498619
[TBL] [Abstract][Full Text] [Related]
7. Experimental autoimmune encephalomyelitis. Augmentation of demyelination by different myelin lipids.
Moore GR; Traugott U; Farooq M; Norton WT; Raine CS
Lab Invest; 1984 Oct; 51(4):416-24. PubMed ID: 6207382
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion.
Raine CS; Scheinberg L; Waltz JM
Lab Invest; 1981 Dec; 45(6):534-46. PubMed ID: 7321526
[TBL] [Abstract][Full Text] [Related]
9. Neuregulin in neuron/glial interactions in the central nervous system. GGF2 diminishes autoimmune demyelination, promotes oligodendrocyte progenitor expansion, and enhances remyelination.
Marchionni MA; Cannella B; Hoban C; Gao YL; Garcia-Arenas R; Lawson D; Happel E; Noel F; Tofilon P; Gwynne D; Raine CS
Adv Exp Med Biol; 1999; 468():283-95. PubMed ID: 10635037
[TBL] [Abstract][Full Text] [Related]
10. The cellular and molecular events of central nervous system remyelination.
Dubois-Dalcq M; Armstrong R
Bioessays; 1990 Dec; 12(12):569-76. PubMed ID: 2080911
[TBL] [Abstract][Full Text] [Related]
11. Survival of oligodendrocytes in chronic relapsing experimental autoimmune encephalomyelitis.
Moore GR; Traugott U; Raine CS
J Neurol Sci; 1984 Aug; 65(2):137-45. PubMed ID: 6481396
[TBL] [Abstract][Full Text] [Related]
12. Immunization with a peptide of Semliki Forest virus promotes remyelination in experimental autoimmune encephalomyelitis.
Mokhtarian F; Safavi F; Sarafraz-Yazdi E
Brain Res; 2012 Dec; 1488():92-103. PubMed ID: 23031637
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions.
Prineas JW; Kwon EE; Goldenberg PZ; Ilyas AA; Quarles RH; Benjamins JA; Sprinkle TJ
Lab Invest; 1989 Nov; 61(5):489-503. PubMed ID: 2811298
[TBL] [Abstract][Full Text] [Related]
14. Oligodendrocyte proliferation and enhanced CNS remyelination after therapeutic manipulation of chronic relapsing EAE.
Raine CS; Hintzen R; Traugott U; Moore GR
Ann N Y Acad Sci; 1988; 540():712-4. PubMed ID: 2462842
[No Abstract] [Full Text] [Related]
15. Remyelination in multiple sclerosis: a new role for neurotrophins?
Althaus HH
Prog Brain Res; 2004; 146():415-32. PubMed ID: 14699977
[TBL] [Abstract][Full Text] [Related]
16. Optic neuritis and chronic relapsing experimental allergic encephalomyelitis: relationship to clinical course and comparison with multiple sclerosis.
Raine CS; Traugott U; Nussenblatt RB; Stone SH
Lab Invest; 1980 Mar; 42(3):327-35. PubMed ID: 7189001
[TBL] [Abstract][Full Text] [Related]
17. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
[TBL] [Abstract][Full Text] [Related]
18. HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis.
Paintlia AS; Paintlia MK; Khan M; Vollmer T; Singh AK; Singh I
FASEB J; 2005 Sep; 19(11):1407-21. PubMed ID: 16126908
[TBL] [Abstract][Full Text] [Related]
19. Identification of oligodendrocyte precursors in the myelinated streak of the adult rabbit retina in vivo.
Morcos Y; Chan-Ling T
Glia; 1997 Oct; 21(2):163-82. PubMed ID: 9336232
[TBL] [Abstract][Full Text] [Related]
20. Remyelination follows antibody-induced central nervous system demyelination.
Sergott RC; Brown MJ; Silberberg DH
Ann Neurol; 1986 Jul; 20(1):94-8. PubMed ID: 3740817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
